Lowenstein represented Aetion in the acquisition of Replica Analytics, assisted by Fasken Martineau DuMoulin LLP. Aetion, the leading regulatory-grade real-world evidence (RWE) technology provider, executed its...
You must be a Standard 1 Year member to access this content.
Lowenstein represented Osmosis in the transaction, while Cravath represented RELX. Elsevier, a global leader in research publishing and information analytics, executed the acquisition of digital health...
You must be a Standard 1 Year member to access this content.
Osler, Hoskin & Harcourt and Lowenstein advised VTS on the acquisition of Lane Technologies, assisted by Fasken Martineau DuMoulin LLP. On October 19, 2021, VTS announced...
You must be a Standard 1 Year member to access this content.
Lowenstein Sandler represented Alloy in the transaction. Alloy, the leading identity decisioning platform for banks and fintech companies, executed its $100 million Series C financing. The funding...
You must be a Standard 1 Year member to access this content.
Lowenstein Sandler represented Sapphire Digital in the transaction, while Kirkland & Ellis represented Zelis. Zelis, a leading payments company in healthcare, entered into a definitive agreement...
You must be a Standard 1 Year member to access this content.
Lowenstein represented Orchard in the transaction. Orchard, the company that is radically simplifying home buying and selling, executed its $100 million Series D funding at over a...
You must be a Standard 1 Year member to access this content.
Lowenstein Sandler represented Celldex Therapeutics in the offering. Celldex Therapeutics, Inc. (Celldex) (Nasdaq: CLDX) executed its $287.5 million public offering of common stock. Jefferies, SVB Leerink,...
You must be a Standard 1 Year member to access this content.
Lowenstein Sandler represented VTS in the transaction. VTS executed the acquisition of Rise Buildings, a Chicago-based startup. Rise Buildings is the property operations and tenant experience technology company...
You must be a Standard 1 Year member to access this content.
